DAgnese619 Profile Banner
Doreen Agnese Profile
Doreen Agnese

@DAgnese619

Followers
761
Following
2K
Media
372
Statuses
1K

surgical oncologist at the james cancer hospital ,columbus oh. annual rider in pelotonia to raise money for cancer research. views are my own

columbus, oh
Joined March 2013
Don't wanna be here? Send us removal request.
@DAgnese619
Doreen Agnese
2 years
Even after fellowship the mentoring continues!
@AndreaLMerrill
Andrea Merrill, MD FACS
2 years
Always learning from @DAgnese619- here she is teaching me when it’s time for a brief conference break for some vitamin D! @ASBrS #asbrs24
1
0
11
@DAgnese619
Doreen Agnese
2 years
Updates from San Antonio. The key word is de-escalation. #asbrs24
@ASBrS
ASBrS
2 years
Monday morning takeaways by Dr Shelley Hwang! How will you utilize these pearls? #asbrs24
0
2
11
@DAgnese619
Doreen Agnese
2 years
Always amazing! How does she do it every year! #asbrs24
@ASBrS
ASBrS
2 years
It’s the session we’ve all been waiting for - Best papers of 2023! #ASBRS24
0
1
6
@ASBrS
ASBrS
2 years
Dog or Muffin? #AI #ASBrS24
0
10
49
@DAgnese619
Doreen Agnese
2 years
Can AI help us to transition to a system where disease is prevented rather than treated? #asbrs24
@ASBrS
ASBrS
2 years
David Gruen, MD delivers #ASBRS24 Keynote Address “Why Medicine is Flatlining & How AI Can Resusitate It”
0
2
6
@JenniferPlichta
Jennifer Plichta MD (she/her)
2 years
👏👏Excellent overview by @chibaAkiko on how social media may impact health outcomes!!🧐🧐 Physician education, patient education, public health notifications, counter misinformation, and more!! 🙌🙌 #ASBRS24
1
7
25
@DAgnese619
Doreen Agnese
2 years
Very interesting study by @AnnaWeissMD regarding genetic testing for surgical decision making. We need to change the way we test as we increase the number of patients tested and assure our patients really understand their future risks of contralateral cancer. #asbrs24 @ASBrS
0
8
14
@SusieSunMD
Susie Sun
2 years
So proud of Alex Moore highlighting the clinical implications of cALND in pts with +TAD. 45% had ⬆️RCB from additional disease on cALND. No data yet to support oncologic safety of omitting cALND for +TAD. @MDAndersonNews @drmediget @ASBrS #ASBrS24 #precisionmatters
2
4
18
@puneetsinghmd
Puneet Singh, MD FACS
2 years
Interesting presentation by @katfleshner on diagnostic delays in young pts - primarily patient delays vs system delays highlighting the need for provider & pt education on recognizing signs and symptoms which may be different in this population #ASBrS24 @ASBrS
0
4
14
@RosenbergerMd
LauraRosenbergerMD
2 years
Excellent Canadian 🇨🇦 study on young women w/#BreastCancer by @katfleshner 👏. Healthcare system working well and opportunities to educate young women re: signs/symptoms of breast cancer. @ASBrS #ASBrS24
1
6
13
@SusieSunMD
Susie Sun
2 years
Important presentation by @AlexaGlencer highlighting NON-guideline concordant care of IBC. In the era of de-escalation, education is needed to avoid non-data backed care. All IBC pts need trimodal therapy with modified radical mastectomy! @ASBrS @MDAndersonNews #ASBrS24
0
6
16
@ASBrS
ASBrS
2 years
Should we exclude anyone from cancer genetic testing? Dr. Euhus says “No” We should be thoughtful about how we use genetic mutation information combined with other risk factors for breast cancer screening and risk reduction. #ASBrS24
0
6
16
@puneetsinghmd
Puneet Singh, MD FACS
2 years
Key considerations in how genetic variants affect care by @DrBeaMD #ASBrS24 @ASBrS
0
6
11
@DAgnese619
Doreen Agnese
2 years
Are we ready for the ultimate breast conservation? More data to come!
@ASBrS
ASBrS
2 years
A fantastic update by ⁦@HenryKuerer⁩ on eliminating breast surgery after neoadjuvant systemic therapy. #ASBrS24
0
2
5
@DAgnese619
Doreen Agnese
2 years
Excellent discussion of genetic panel testing by @jenniferplichta. The key is shared decision making. #asbrs24
0
3
10
@DAgnese619
Doreen Agnese
2 years
Great talk about personalizing radiation care from a familiar face to the osu team! @Dr_Julia_White
@puneetsinghmd
Puneet Singh, MD FACS
2 years
Dr. Julia White presents on radiation genomics including ongoing clinical trials using commercially available genomic assays to select low risk breast cancers for omission of RT #ASBrS24 @ASBrS
0
1
5
@DAgnese619
Doreen Agnese
2 years
Great talk on the use of MRI in beast cancer. There are some appropriate uses but it should not be used routinely in the preoperative work up of breast cancer. @ASBrS #ASBRS24
0
3
8
@puneetsinghmd
Puneet Singh, MD FACS
2 years
An excellent @ASBrS Annual Meeting Scientific Committee meeting at #ASBrS24 led by @SarahLBlairMD & @drmediget! Looking forward to the scientific presentations! @RosenbergerMd @DAgnese619 @AnnaWeissMD @preeti_subhedar @OKantorMD @MarissaHMcNatt @SOSENI1
2
9
36
@DAgnese619
Doreen Agnese
2 years
Ready for a great day at #ASBrS24! And can I just say a heartfelt thank you to @ASBrS for a caffeinated coffee alternative for us non-coffee drinkers?
1
0
4
@RosenbergerMd
LauraRosenbergerMD
2 years
Outstanding 👏 work by @DukeSurgOnc @JenniferPlichta. Novel 💡 staging model for de novo metastatic #BreastCancer. #Novel #Impactful @JCO_ASCO 2023 ➡️ now validated in an international cohort of 5️⃣ countries 🇫🇷 🇲🇽 🇳🇱 🇨🇦 🇪🇸
0
4
23